{"id":"https://openalex.org/W2017648748","doi":"https://doi.org/10.1021/mp034017a","title":"An Azepanone-Based Inhibitor of Human Cathepsin K with Improved Oral Bioavailability in the Rat and the Monkey","display_name":"An Azepanone-Based Inhibitor of Human Cathepsin K with Improved Oral Bioavailability in the Rat and the Monkey","alternate_titles":[],"publication_year":2003,"publication_date":"2003-11-22","ids":{"openalex":"https://openalex.org/W2017648748","doi":"https://doi.org/10.1021/mp034017a","mag":"2017648748","pmid":"https://pubmed.ncbi.nlm.nih.gov/15832505"},"language":"en","primary_location":{"id":"doi:10.1021/mp034017a","doi":"https://doi.org/10.1021/mp034017a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp034017a","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2017648748"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109720987","display_name":"Robert W. Marquis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Robert W. Marquis","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103397583","display_name":"Keith W. Ward","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keith W. Ward","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001756937","display_name":"Theresa J. Roethke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theresa Roethke","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101844548","display_name":"Brian R. Smith","orcid":"https://orcid.org/0000-0001-6190-6269","observed_orcids":["https://orcid.org/0000-0001-6190-6269"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Brian R. Smith","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002726689","display_name":"Yu Ru","orcid":"https://orcid.org/0009-0005-1988-8147","observed_orcids":["https://orcid.org/0009-0005-1988-8147"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yu Ru","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023131186","display_name":"Dennis S. Yamashita","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dennis S. Yamashita","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113873356","display_name":"Thaddeus A. Tomaszek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thaddeus A. Tomaszek","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048946147","display_name":"Peter D. Gorycki","orcid":"https://orcid.org/0000-0001-6366-7310","observed_orcids":["https://orcid.org/0000-0001-6366-7310"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter D. Gorycki","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015754493","display_name":"H.-Y. Cheng","orcid":"https://orcid.org/0000-0002-2400-4028","observed_orcids":["https://orcid.org/0000-0002-2400-4028"]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H.-Y. Cheng","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111561681","display_name":"Ian E. James","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ian E. James","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024570437","display_name":"George B. Stroup","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George B. Stroup","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050948761","display_name":"Michael W. Lark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael W. Lark","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013116316","display_name":"Maxine Gowen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maxine Gowen","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019768909","display_name":"Daniel F. Veber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114143","display_name":"GlaxoSmithKline (United States)","ror":"https://ror.org/025vn3989","country_code":"US","type":"company","lineage":["https://openalex.org/I188950975","https://openalex.org/I4210114143"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Daniel F. Veber","raw_affiliation_strings":["Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Drug Metabolism and Pharmacokinetics, Mechanistic Enzymology, Computational, Analytical and Structural Sciences, and Bone and Cartilage Biology, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, Pennsylvania 19426, and 709 Swedeland Road, King of Prussia, Pennsylvania 19406","institution_ids":["https://openalex.org/I4210114143"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019768909","https://openalex.org/A5109720987"],"corresponding_institution_ids":["https://openalex.org/I4210114143"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.4394,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.57111641,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":93},"biblio":{"volume":"1","issue":"1","first_page":"97","last_page":"100"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.00570000009611249,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cathepsin-k-inhibitors","display_name":"cathepsin K inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9789999723434448},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6179999709129333},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.49399998784065247},{"id":"https://openalex.org/keywords/monkeys","display_name":"monkeys","score":0.824999988079071},{"id":"https://openalex.org/keywords/enzyme-inhibitors","display_name":"enzyme inhibitors","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.9673824310302734},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7699978351593018},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7540037631988525},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6135361790657043},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5961165428161621},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.508098840713501},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48390039801597595},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.44475388526916504},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.43650195002555847},{"id":"https://openalex.org/C167844969","wikidata":"https://www.wikidata.org/wiki/Q426245","display_name":"Cathepsin","level":3,"score":0.4127603769302368},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2878364324569702},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23314645886421204},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19593793153762817},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.1312427520751953},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.04598879814147949},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001381","descriptor_name":"Azepines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002403","descriptor_name":"Cathepsins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D015853","descriptor_name":"Cysteine Proteinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056657","descriptor_name":"Cathepsin K","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/mp034017a","doi":"https://doi.org/10.1021/mp034017a","is_oa":false,"landing_page_url":"https://doi.org/10.1021/mp034017a","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:15832505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15832505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1988329323","https://openalex.org/W1989316750","https://openalex.org/W2003060201","https://openalex.org/W2031749987","https://openalex.org/W2039218698","https://openalex.org/W2047186810","https://openalex.org/W2049528994","https://openalex.org/W2060365395","https://openalex.org/W2072073837","https://openalex.org/W2090177025","https://openalex.org/W2105649494","https://openalex.org/W2137303255","https://openalex.org/W2161115679","https://openalex.org/W2162822427","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W2124507977","https://openalex.org/W2076364177","https://openalex.org/W1559729232","https://openalex.org/W2178809611","https://openalex.org/W2083359593","https://openalex.org/W2076718719","https://openalex.org/W1965752262","https://openalex.org/W2026224020","https://openalex.org/W2116428224","https://openalex.org/W2044452648"],"abstract_inverted_index":{"Pharmacokinetic":[0],"evaluation":[1],"of":[2,17,33,71,81,94],"the":[3,20,25,36,39,63,69,79,92,104,108],"potent":[4],"azepanone-based":[5],"cathepsin":[6],"K":[7],"inhibitor":[8],"3":[9,34,72],"showed":[10],"that":[11,97],"it":[12],"has":[13],"an":[14],"oral":[15,31,100],"bioavailability":[16,70,101],"42%":[18],"in":[19,24,35,57,73,102],"rat":[21,37,105],"and":[22,38,51,56,107],"4.8%":[23],"monkey.":[26],"The":[27],"less":[28],"than":[29],"optimal":[30],"bioavailabilities":[32],"monkey":[40,109],"precluded":[41],"this":[42],"analogue":[43],"from":[44],"being":[45],"subjected":[46],"to":[47,77,91],"more":[48],"detailed":[49],"pharmacokinetic":[50],"pharmacodynamic":[52],"analyses.":[53],"In":[54],"vitro":[55],"vivo":[58],"studies":[59,88],"aimed":[60],"at":[61],"identifying":[62],"mechanisms":[64],"which":[65],"may":[66],"be":[67],"limiting":[68],"these":[74],"species":[75],"served":[76],"guide":[78],"syntheses":[80],"subsequent":[82],"analogues":[83],"for":[84],"further":[85],"evaluation.":[86],"These":[87],"have":[89],"led":[90],"identification":[93],"azepanone":[95],"6":[96],"possesses":[98],"improved":[99],"both":[103],"(66.3%)":[106],"(23.4%).":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2017648748","counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}
